Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study Bridging Pre-Transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)

NCT05787574 is registered in ClinicalTrials.gov with Joseph Oved as lead sponsor.

NCT NCT05787574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05787574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study Bridging Pre-Transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)
Lead sponsor
Joseph Oved
Phase
Phase 2
Overall status
Recruiting
Start date
March 15, 2023
Completion date
March 31, 2027
Enrollment
39 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune lymphoproliferative, immune system diseases, primary immune regulatory disorder